Biblio Discovery — Demo Discovery Service

14 hasil untuk "Jonathan Low"

Menampilkan 1–14 · 0,43 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Feasibility of a mobile health intervention to motivate adolescent fitness and high-intensity exercise adherence (Motivating Adolescent Fitness (MOTAFIT)): protocol for a randomised controlled trial

    Alison M McManus; Jonathan Low; Matthew Cocks dkk.

    BMJ Open, Vol. 16 No. 2 · 2026 · Inggris · DOAJ Scopus

    Introduction Most adolescents fail to achieve recommended levels of vigorous-intensity physical activity, despite the established benefits for cardiorespiratory fitness and vascular health. Supervised interventions can be effective, but are resource-intensive and lack scalability. Mobile health…

    Juga tersedia di: DOAJ

  2. Artikel Jurnal

    The management of concomitant septic arthritis of the knee and femoral osteomyelitis – A case series and literature review

    Chee Chung Jonathan Low; Rex Premchand Anthony Xavier; Gek Meng Tan dkk.

    Trauma Case Reports, Vol. 32 · 2021 · Inggris · DOAJ Scopus

    We present a case series comprising three patients with concomitant septic arthritis of the knee and osteomyelitis of the femur. Early advanced imaging rendered the accurate diagnosis of the condition and the appropriate surgical approach and technique used to treat the infection. Repeated…

  3. Artikel Jurnal Teks lengkap

    Identification of Small Molecule Activators of BMP Signaling

    Karen Vrijens; Wenwei Lin; Jimmy Cui dkk.

    PLoS ONE, Vol. 8 No. 3 · 2013 · Inggris · PLOS Scopus

    Bone Morphogenetic Proteins (BMPs) are morphogens that play a major role in regulating development and homeostasis. Although BMPs are used for the treatment of bone and kidney disorders, their clinical use is limited due to the supra-physiological doses required for therapeutic efficacy causing…

    Juga tersedia di: DOAJ

  4. Artikel Jurnal

    Mobile Health Biometrics to Enhance Exercise and Physical Activity Adherence in Type 2 Diabetes (MOTIVATE-T2D): protocol for a feasibility randomised controlled trial

    Joel Singer; Helen Jones; Céu Mateus dkk.

    BMJ Open, Vol. 11 No. 11 · 2021 · Inggris · DOAJ Scopus

    Introduction Exercise and physical activity (PA) are fundamental to the treatment of type 2 diabetes. Current exercise and PA strategies for newly diagnosed individuals with type 2 diabetes are either clinically effective but unsuitable in routine practice (supervised exercise) or suitable in…

  5. Artikel Jurnal

    Effectiveness of Traditional Strength vs. Power Training on Muscle Strength, Power and Speed with Youth: A Systematic Review and Meta-Analysis

    David G. Behm; James D. Young; Joseph H. D. Whitten dkk.

    Frontiers in Physiology, Vol. 8 · 2017 · Inggris · DOAJ Scopus

    Numerous national associations and multiple reviews have documented the safety and efficacy of strength training for children and adolescents. The literature highlights the significant training-induced increases in strength associated with youth strength training. However, the effectiveness of…

  6. Artikel Jurnal

    An open-source screening platform accelerates discovery of drug combinations

    William C. Wright; Min Pan; Gregory A. Phelps dkk.

    Nature Communications, Vol. 16 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Drug combinations are essential to modern medicine, but their discovery remains slow and inefficient as experimental complexity expands rapidly with each additional drug tested. Although modern liquid handling systems enable complex and highly customizable experimental designs, a lack of…

  7. Artikel Jurnal

    Mobile Health Biometrics to Enhance Exercise and Physical Activity Adherence in Type 2 Diabetes (MOTIVATE-T2D): a decentralised feasibility randomised controlled trial delivered across the UK and Canada

    Joel Singer; Helen Jones; Céu Mateus dkk.

    BMJ Open, Vol. 15 No. 3 · 2025 · Inggris · DOAJ Scopus

    Objectives Assess the feasibility of a mobile health (mHealth)-supported home-delivered physical activity (PA) intervention (MOTIVATE-T2D) in people with recently diagnosed type 2 diabetes (T2D).Design Feasibility multicentre, parallel group, randomised controlled trial (RCT).Setting Participants…

  8. Artikel Jurnal

    A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics

    Hyeong-Min Lee; William C. Wright; Min Pan dkk.

    Nature Communications, Vol. 14 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Combination chemotherapy is crucial for successfully treating cancer. However, the enormous number of possible drug combinations means discovering safe and effective combinations remains a significant challenge. To improve this process, we conduct large-scale targeted CRISPR knockout…

  9. Artikel Jurnal

    Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid

    Min Pan; Yinwen Zhang; William C. Wright dkk.

    Nature Communications, Vol. 16 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Retinoic acid (RA) is a standard-of-care neuroblastoma drug thought to be effective by inducing differentiation. Curiously, RA has little effect on primary human tumors during upfront treatment but can eliminate neuroblastoma cells from the bone marrow during post-chemo maintenance…

  10. Artikel Jurnal

    17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma

    Shivendra Singh; Ahmed Abu-Zaid; Wenwei Lin dkk.

    iScience, Vol. 24 No. 1 · 2021 · Inggris · DOAJ Scopus

    Summary: Histone lysine demethylases (KDMs) play critical roles in oncogenesis and therefore may be effective targets for anticancer therapy. Using a time-resolved fluorescence resonance energy transfer demethylation screen assay, in combination with multiple orthogonal validation approaches, we…

  11. Artikel Jurnal

    The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma

    Min Pan; William C. Wright; Richard H. Chapple dkk.

    Nature Communications, Vol. 12 No. 1 · 2021 · Inggris · DOAJ Scopus

    CX-5461 recently progressed through phase I clinical trial as a first-inhuman inhibitor of RNA-POL I. Here, the authors demonstrate that CX-5461 synergizes with topoisomerase I inhibitors to inhibit neuroblastoma cells and that its primary target in this disease is topoisomerase II beta and not…